--- title: "US Small-Cap Capital Deployment Accelerates Amid Tech and Biotech Pivots" type: "News" locale: "en" url: "https://longbridge.com/en/news/292180977.md" description: "A diverse group of under-the-radar US equities is executing over USD 150 million in fresh capital raises and strategic restructurings in mid-2026, driven by AI infrastructure demand and clinical pipeline milestones." datetime: "2026-07-09T10:02:52.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292180977.md) - [en](https://longbridge.com/en/news/292180977.md) - [zh-HK](https://longbridge.com/zh-HK/news/292180977.md) --- # US Small-Cap Capital Deployment Accelerates Amid Tech and Biotech Pivots A diverse basket of US small-cap and micro-cap companies is accelerating strategic capital deployment and operational pivots this quarter, with total deal values and capital raises across these firms exceeding USD 150 million, according to regulatory filings and people familiar with the matter. Recent market data indicates that capital is heavily rotating into AI infrastructure providers and late-stage biotech firms with clear commercialization targets. Meanwhile, legacy logistics operators and crypto infrastructure plays are facing mounting restructuring pressure, pushing several to seek legal settlements to preserve critical cash flows. ### Alpha Compute Corporation (ALP.US) The AI GPU-as-a-service provider closed a binding USD 32.2 million lease agreement in mid-2026 for an enterprise-scale NVIDIA B200 deployment. The two-year contract is expected to generate USD 16.1 million in annual recurring revenue, according to people familiar with the matter. The company is actively expanding its enterprise AI workloads through hardware-level encrypted confidential cloud architectures. ### Summit Therapeutics Inc (SMMT.US) The oncology biopharmaceutical firm is nearing broader commercial validation after its bispecific antibody, ivonescimab, demonstrated a statistically significant overall survival benefit in a Phase 3 study for NSCLC patients in late May 2026. The company swiftly launched a public offering in June to capitalize on the clinical momentum. ### Schrodinger Inc (SDGR.US) The computational drug discovery platform raised its full-year software outlook, targeting an annual contract value between USD 218 million and USD 228 million for 2026. In the first quarter of 2026, software ACV rose 12% year-over-year to USD 28.4 million as the transition to a hosted software licensing model gathers pace. ### Intensity Therapeutics Inc (INTS.US) The late-stage biotech firm significantly extended its cash runway via a USD 60 million at-the-market financing facility. Exiting the first quarter of 2026 with USD 10.2 million in cash equivalents, the company is preparing to advance Phase 3 trials for its INT230-6 intratumoral therapy, according to a mid-year operational update. ### Solidion Technology Inc (STI.US) The advanced battery materials developer completed a USD 35 million private placement at a premium to market rates in June 2026. The firm is also targeting a SpaceX-focused treasury strategy to manage its cash reserves. While the stock has seen recent volatility, the fresh capital injection provides a buffer for its silicon-rich solid-state battery pipeline. ### Dawson Geophysical Co (DWSN.US) The onshore seismic data provider reported a 113% year-over-year surge in first-quarter 2026 fee revenues, reaching USD 32.5 million. Net income came in at USD 7.7 million, or USD 0.25 per share, with adjusted EBITDA hitting USD 10.9 million, driven by recovering North American oil and gas exploration demand. ### AvePoint Inc (AVPT.US) The cloud data governance company highlighted a growing AI visibility gap in enterprises in a June 2026 study, noting that nearly half of workforces now rely on AI agents daily. The firm continues to lean heavily into its Microsoft ecosystem integration to capture enterprise SaaS demand. ### Okeanis Eco Tankers Corp (ECO.US) The crude oil tanker operator, managing a fleet of 16 modern VLCCs and Suezmax vessels, filed a flurry of regulatory changes regarding voting matters in May 2026. The company is navigating shifting global crude trade routes against a backdrop of volatile spot freight rates. ### Singularity Future Technology Ltd (SGLY.US) The logistics solutions provider agreed to a USD 5.8 million cash settlement in July 2026 to resolve a long-standing securities class action lawsuit. With trailing 12-month revenue sitting at a mere USD 1.33 million as of March 2026, the company continues to struggle with its overarching business transition. ### Bitcoin Depot Inc (BTMWQ.US) Trading under an OTC ticker, the crypto ATM operator has been navigating severe restructuring headwinds following Chapter 11 proceedings. The stock remains heavily depressed as the broader physical crypto infrastructure sector undergoes painful consolidation. _This article does not constitute investment advice._ ### Related Stocks - [STI.US](https://longbridge.com/en/quote/STI.US.md) - [DWSN.US](https://longbridge.com/en/quote/DWSN.US.md) - [SDGR.US](https://longbridge.com/en/quote/SDGR.US.md) - [AVPT.US](https://longbridge.com/en/quote/AVPT.US.md) - [SGLY.US](https://longbridge.com/en/quote/SGLY.US.md) - [BTMWQ.US](https://longbridge.com/en/quote/BTMWQ.US.md) - [SMMT.US](https://longbridge.com/en/quote/SMMT.US.md) - [ECO.US](https://longbridge.com/en/quote/ECO.US.md) - [ALP.US](https://longbridge.com/en/quote/ALP.US.md) - [INTS.US](https://longbridge.com/en/quote/INTS.US.md) ## Related News & Research - [AvePoint executives to present at upcoming investor conferences](https://longbridge.com/en/news/294409475.md) - [08:52 ETKuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm](https://longbridge.com/en/news/293935876.md) - [Summit Therapeutics Flags Going Concern Risk Over Cash Needs](https://longbridge.com/en/news/293778161.md) - [SMMT: Ivonescimab advances in Phase III, but funding shortfall raises going concern risk](https://longbridge.com/en/news/293661623.md) - [Summit Therapeutics Q2 net loss narrows on lower stock compensation](https://longbridge.com/en/news/293662165.md)